Responsibility Report

Overview

The report highlights the company's rapid development and FDA emergency authorization of its COVID-19 antibody cocktail, REGEN-COV, alongside FDA approval of Inmazeb for Ebola. It reports progress toward environmental goals, including 20.5% renewable energy and 100% waste diversion from landfills. The report also describes expanded diversity, equity and inclusion initiatives and independent verification of selected Scope 1 and 2 emissions, water usage and waste data.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Publication date: 1 April 2021
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Provider
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services